These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells. Maghazachi AA Pharmacol Rev; 2005 Sep; 57(3):339-57. PubMed ID: 16109839 [TBL] [Abstract][Full Text] [Related]
9. Coordination of activating and inhibitory signals in natural killer cells. Chiesa S; Tomasello E; Vivier E; Vély F Mol Immunol; 2005 Feb; 42(4):477-84. PubMed ID: 15607802 [TBL] [Abstract][Full Text] [Related]
10. Contrasting roles of DAP10 and KARAP/DAP12 signaling adaptors in activation of the RBL-2H3 leukemic mast cell line. Anfossi N; Lucas M; Diefenbach A; Bühring HJ; Raulet D; Tomasello E; Vivier E Eur J Immunol; 2003 Dec; 33(12):3514-22. PubMed ID: 14635062 [TBL] [Abstract][Full Text] [Related]
11. Signaling pathways engaged by NK cell receptors: double concerto for activating receptors, inhibitory receptors and NK cells. Tomasello E; Bléry M; Vély F; Vivier E Semin Immunol; 2000 Apr; 12(2):139-47. PubMed ID: 10764622 [TBL] [Abstract][Full Text] [Related]
12. Natural killer cells: detectors of stress. Luci C; Tomasello E Int J Biochem Cell Biol; 2008; 40(11):2335-40. PubMed ID: 18595768 [TBL] [Abstract][Full Text] [Related]
13. KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions. Tomasello E; Vivier E Eur J Immunol; 2005 Jun; 35(6):1670-7. PubMed ID: 15884055 [TBL] [Abstract][Full Text] [Related]
14. Paired inhibitory and activating receptor signals. Taylor LS; Paul SP; McVicar DW Rev Immunogenet; 2000; 2(2):204-19. PubMed ID: 11258418 [TBL] [Abstract][Full Text] [Related]
15. NK cells and cancer immunosurveillance. Waldhauer I; Steinle A Oncogene; 2008 Oct; 27(45):5932-43. PubMed ID: 18836474 [TBL] [Abstract][Full Text] [Related]
16. The receptors regulating natural cytotoxic effector functions. Nikolova M; Boumsell L; Bensussan A Arch Immunol Ther Exp (Warsz); 2001; 49(2):91-9. PubMed ID: 11348024 [TBL] [Abstract][Full Text] [Related]
17. The effect of silencing NKG2D through RNA interference on receptor functions in interleukin-2-activated human natural killer cells. Baeriswyl V; Wodnar-Filipowicz A; Kalberer CP Haematologica; 2006 Nov; 91(11):1538-41. PubMed ID: 17043026 [TBL] [Abstract][Full Text] [Related]
18. NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells. Poggi A; Prevosto C; Zancolli M; Canevali P; Musso A; Zocchi MR Ann N Y Acad Sci; 2007 Aug; 1109():47-57. PubMed ID: 17785290 [TBL] [Abstract][Full Text] [Related]
19. NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells. Upshaw JL; Arneson LN; Schoon RA; Dick CJ; Billadeau DD; Leibson PJ Nat Immunol; 2006 May; 7(5):524-32. PubMed ID: 16582911 [TBL] [Abstract][Full Text] [Related]
20. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Radaeva S; Sun R; Jaruga B; Nguyen VT; Tian Z; Gao B Gastroenterology; 2006 Feb; 130(2):435-52. PubMed ID: 16472598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]